rediff.com
REAL-TIME QUOTE
Enter Company or MF
e.g. Tata motors, Reliance MF, 500570
Suven Pharmaceuticals Ltd. - Research Center
543064 SUVENPHAR Group (B) BSE data
Add to watchlist
 
Back to Company Page
Results
Statement
More
Profit loss account
(Rs crore)
Mar ' 20 Mar ' 19
Income
Operating income 833.79 377.83
Expenses
Material consumed 230.14 103.74
Manufacturing expenses 104.80 50.77
Personnel expenses 73.72 29.63
Selling expenses - -
Adminstrative expenses 39.98 22.15
Expenses capitalised - -
Cost of sales 448.64 206.28
Operating profit 385.15 171.55
Other recurring income 18.12 0.60
Adjusted PBDIT 403.26 172.15
Financial expenses 21.81 2.79
Depreciation 23.86 11.50
Other write offs - -
Adjusted PBT 357.59 157.87
Tax charges 87.51 48.59
Adjusted PAT 270.08 109.27
Non recurring items -0.82 -
Other non cash adjustments - -
Reported net profit 269.26 109.27
Earnigs before appropriation 660.25 429.00
Equity dividend 50.56 15.17
Preference dividend - -
Dividend tax 13.08 3.92
Retained earnings 596.60 409.91

Mutual Fund Selector

Find the fund that is right for you

Buy? Sell? Hold?

Get the Latest Stock Tips
Close
Add Suven Pharmaceuticals Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Suven Pharmaceuticals Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close